Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.13 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.13 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.13 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.13 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.372EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.372ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.372ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.18.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.18.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.18.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.18.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.18.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used